Patents by Inventor Tomas Björklund

Tomas Björklund has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11328601
    Abstract: A computer-implemented method can comprise determining, by a system operatively coupled to a processor, points of interest comprising image coordinates in a set of images captured by an optical camera of a moving vehicle, determining, by the system, whether a multi-match exists in the set of images, in response to determining that the multi-match does not exist, rejecting, by the system, the points of interest, in response to determining that the multi-match exists, determining, by the system, whether the points of interest represent a false-positive determination of a stationary object, in response to determining that the points of interest are in motion and correspond to a false-positive, rejecting, by the system, the points of interest, and in response to determining that the points of interest are stationary and do not correspond to a false-positive, initiating, by the system, collision avoidance to avoid a stationary object corresponding to the points of interest.
    Type: Grant
    Filed: February 22, 2021
    Date of Patent: May 10, 2022
    Assignee: VOLVO CAR CORPORATION
    Inventors: Malte Isaksson, Tomas Björklund
  • Publication number: 20210107947
    Abstract: Methods for identifying polypeptides, e.g. derived from HSV pUL22 protein, which when displayed on a capsid confer a desired property to viral particles comprising such capsids, as well as methods for designing and manufacturing viral vectors and viral particles with improved properties. The identification method is based on a capsid library in which the capsid variant does not form part of the viral genome which contains a barcode and in which the barcode associated with the capsid variant is determined by sequencing before the viral vector is used. Thus, the prevalence of the capsid variant in a biological sample may be determined by sequencing of the barcode alone.
    Type: Application
    Filed: February 14, 2019
    Publication date: April 15, 2021
    Inventors: Tomas BJÖRKLUND, Marcus DAVIDSSON
  • Patent number: 9593312
    Abstract: The present invention relates to a one-vector expression system comprising a sequence encoding two polypeptides, such as tyrosine hydroxylase (TH) and GTP-cyclohydrolase 1 (GCH1). The two polypeptides can be should preferentially be expressed at a ratio between 3:1 and 15:1, such as between 3:1 and 7:1. The invention is useful in the treatment of catecholamine deficient disorders, such as dopamine deficient disorders including but not limited to Parkinson's Disease. Moreover, the present invention provides a method to deliver the vector construct in order to limit the increased production of the catecholamine to the cells in need thereof.
    Type: Grant
    Filed: April 1, 2014
    Date of Patent: March 14, 2017
    Assignee: Genepod Therapeutics AB
    Inventors: Tomas Björklund, Anders Björklund, Deniz Kirik
  • Publication number: 20150065560
    Abstract: The present invention relates to a one-vector expression system comprising a sequence encoding two polypeptides, such as tyrosine hydroxylase (TH) and GTP-cyclohydrolase 1 (GCH1). The two polypeptides can be should preferentially be expressed at a ratio between 3:1 and 15:1, such as between 3:1 and 7:1. The invention is useful in the treatment of catecholamine deficient disorders, such as dopamine deficient disorders including but not limited to Parkinson's Disease. Moreover, the present invention provides a method to deliver the vector construct in order to limit the increased production of the catecholamine to the cells in need thereof.
    Type: Application
    Filed: April 1, 2014
    Publication date: March 5, 2015
    Inventors: Tomas Björklund, Anders Björklund, Deniz Kirik
  • Publication number: 20120309816
    Abstract: The present invention relates to a one-vector expression system comprising a sequence encoding two polypeptides, such as tyrosine hydroxylase (TH) and GTP-cyclohydrolase 1 (GCH1). The two polypeptides can be should preferentially be expressed at a ratio between 3:1 and 15:1, such as between 3:1 and 7:1. The invention is useful in the treatment of catecholamine deficient disorders, such as dopamine deficient disorders including but not limited to Parkinson's Disease. Moreover, the present invention provides a method to deliver the vector construct in order to limit the increased production of the catecholamine to the cells in need thereof.
    Type: Application
    Filed: November 9, 2010
    Publication date: December 6, 2012
    Applicant: GENEPOD THERAPEUTICS AB
    Inventors: Tomas Björklund, Anders Björklund, Deniz Kirik